Theophylline
Theo-24, Theophylline
Methylxanthine
NADAC/unit
$0.0992
No Shortage
Tier 1: 132.8%
18 Manufacturers
38 ANDAs
vs. brand Theo-24: Generic saves up to 99% per unit
Market Intelligence
2025-08-20 Class II Recall: Glenmark Pharmaceuticals Inc., USA
2025-06-04 Class II Recall: Glenmark Pharmaceuticals Inc., USA
Generic Manufacturers
ALEMBIC PHARMACEUTICALS LTDAMNEAL EU LTDANNORA PHARMA PRIVATE LTDBIONPHARMA INCCHARTWELL MOLECULAR HOLDINGS LLCENDO OPERATIONS LTDGLENMARK PHARMACEUTICALS LTDHARMAN FINOCHEM LTDHERITAGE PHARMA LABS INC DBA AVET PHARMACEUTICALS LABS INCMPP PHARMA LLCNOSTRUM PHARMACEUTICALS LLCPHARMACEUTICAL ASSOCIATES INCRHODES PHARMACEUTICALS LPSTRIDES PHARMA GLOBAL PTE LTDTEVA PHARMACEUTICALS INCTRIS PHARMA INCVELZEN PHARMA PVT LTDZYDUS LIFESCIENCES LTD
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.